IQVIA™ Real-World Insights Bibliography

Belgian cost-utility analysis of Lucentis (ranibizumab) in wet age-related macular degeneration.
Author(s): Moeremans K, Annemans L, Lecomte P
Affiliations(s): 
Publication(s):  ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
Document Type(s): Poster,
Countries: Belgium,
C:
Y:
Ophthalmology,
2007
  L:
A:
English
Cost utility,
  Add to report
 
 
The impact of glaucoma coding in a large claims database.
Author(s): Lee P, Levin L, Walt J, Chiang T, Doyle J, Stern L, Dolgitser M
Affiliations(s): 
Publication(s):  American Journal of Ophthalmology, 2007, 143(5): 867-70
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Ophthalmology,
2007
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
First Page Previous Page  11 of 11